Related Experiment Video
Updated: Apr 7, 2026
07:49
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
12.0K
Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma
1Department of Ophthalmology, Norfolk and Norwich University Hospital, Colney Lane, Norwich, Norfolk, NR4 7UY, UK, david.broadway@nnuh.nhs.uk.
Drugs & Aging
|July 3, 2015
Summary
Glaucoma management often involves daily eye drops to lower intraocular pressure (IOP). This review examines medical therapies for glaucoma and discusses adherence challenges in elderly patients using topical ocular hypotensive drugs.
Area of Science:
- Ophthalmology
- Geriatric Medicine
- Clinical Pharmacy
Background:
- Glaucoma is a leading cause of global visual impairment, primarily affecting the elderly.
- Elevated intraocular pressure (IOP) and advanced age are key risk factors for glaucoma.
- Topical ocular hypotensive drugs are the primary medical treatment for managing glaucoma and preventing vision loss.
Purpose of the Study:
- To review current medical therapies for glaucoma.
- To discuss adherence issues related to topical glaucoma medications in the elderly population.
- To highlight the clinical implications of medication adherence in glaucoma management.
Main Methods:
- Clinical review of medical therapies for glaucoma.
- Analysis of adherence challenges associated with topical ocular hypotensive drugs.
- Discussion of adverse effects and drug interactions in elderly glaucoma patients.
Main Results:
- Topical ocular hypotensive drugs are widely used but can cause adverse effects and drug interactions.
- Adherence to daily glaucoma eye drop regimens is crucial for treatment success.
- Evidence regarding adherence differences between elderly and younger glaucoma patients is limited.
- Strategies to improve adherence in the elderly remain poorly understood and addressed.
Conclusions:
- Effective glaucoma management relies on consistent adherence to topical ocular hypotensive medications.
- Further research is needed to understand and address adherence barriers in elderly glaucoma patients.
- Optimizing adherence is critical for slowing disease progression and preserving vision in the aging population.
Related Concept Videos
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
814
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
814
01:15Drug Dosing: Geriatric Patients
358
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
358
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
327
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
327
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
348
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
348
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
321
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
321
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K